Lipodystrophy following Covid-19 Vaccination: A case report

Mehrnaz Shakarami; Farnaz Sinaei; Bardiya Ghaderi Yazdi; Bentolhoda Ziaadini

Vaccine: X (Aug 2024)

Lipodystrophy following Covid-19 Vaccination: A case report

Mehrnaz Shakarami,
Farnaz Sinaei,
Bardiya Ghaderi Yazdi,
Bentolhoda Ziaadini

Affiliations

Mehrnaz Shakarami: Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
Farnaz Sinaei: Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
Bardiya Ghaderi Yazdi: Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
Bentolhoda Ziaadini: Neurology Research Center, Kerman University of Medical Sciences, Kerman, Iran; Corresponding author.

Journal volume & issue: Vol. 19
p. 100513

Abstract

Read online

Lipodystrophy is a medical condition characterized by complete or partial loss of adipose tissue. The etiology of lipoatrophy can be congenital or acquired, including traumatic, iatrogenic, or idiopathic. Rarely, vaccination can cause lipodystrophy. Here, we report the first case of lipodystrophy associated with the COVID-19 Sinopharm vaccine in a 55-year-old woman.

Published in Vaccine: X

ISSN: 2590-1362 (Online)
Publisher: Elsevier
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
Website: https://www.journals.elsevier.com/vaccine-x

About the journal

Abstract

Keywords